Delivery Order 75A50122D00002-75A50124F61016

Award Date 8/30/24
Potential Completion Date 2/21/26
Potential Value $1.7M
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Research Triangle Park, NC 27709, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price delivery order awarded by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response to Glaxosmithkline, LLC, a pharmaceutical company, for the production of influenza vaccine master and working seed lots. The contract is part of the Pandemic Influenza Preparedness and Response 2012-2016 program and has a potential value of $533,988.00. There is no set-aside designation for this award. The contract supports the...
This federal contract award, valued at $22,877,697.00, was issued by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency within the U.S. Department of Health and Human Services (HHS). The purpose of this Delivery Order is to procure an Influenza A/Astrakhan/3212/2020 (H5N8) virus vaccine candidate and conduct the associated clinical trial. This award was made to the prime contractor, Glaxosmithkline, LLC, a foreign-owned, for-profit pharmaceutical...
This $563,504 firm fixed price delivery order was awarded by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) to Glaxosmithkline, LLC, a pharmaceutical company that provides vaccines, antiviral medications, and other pharmaceutical products to U.S. government agencies. The order is part of the Pandemic Influenza Preparedness and Response 2016-2021 indefinite delivery, indefinite quantity (IDIQ) contract and does not have a...
This is a firm fixed-price delivery order contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency, to Glaxosmithkline, LLC, a foreign-owned, for-profit pharmaceutical company. The purpose of this task order is to request the fill/finish of one CGMP adjuvant bulk lot under CLIN 0006E and to fill/finish and release the AS03 drug product. The contract has a ceiling value of $444,568.40 and an ultimate completion date of June 30, 2024. This...
This is a delivery order award to Glaxosmithkline, LLC under the Pandemic Influenza Preparedness and Response 2012-2016 indefinite delivery/indefinite quantity (IDIQ) contract with the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response (HHS ASPR). The $2,812,228.00 fixed-price order is for the production of clinical lots of a CGMP (current good manufacturing practice) influenza vaccine. This supports the Acquisition of Medical...
This is a $2,603,484.86 firm fixed price purchase order awarded by the U.S. Department of Health and Human Services to Glaxosmithkline, LLC for the supply of influenza vaccine for the 2015-2016 season. The contract did not have a set-aside designation. Glaxosmithkline, a pharmaceutical company that provides vaccines and other products to federal agencies, was the prime contractor on this award. The contract was performed at Glaxosmithkline's facilities in Research Triangle Park, North...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to GlaxoSmithKline, LLC, a pharmaceutical company, for the provision of influenza virus vaccines. The order was issued under contract SPE2DP18D0006 and has a firm fixed price ceiling value of $17,193.60. The order was awarded on October 16, 2018, with a performance completion date of November 5, 2018. The contract does not have a set-aside designation. GlaxoSmithKline has received multiple federal contract awards and grants...
This is a $499,100 firm fixed price delivery order awarded by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response to Glaxosmithkline, LLC. The order is for pharmaceutical goods and services under the Pandemic Influenza Preparedness and Response 2016-2021 multiple award contract. Glaxosmithkline, a foreign-owned for-profit pharmaceutical company, provides a range of products to U.S. government agencies including influenza and hepatitis...
The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response awarded a $597,821 firm fixed price delivery order contract to Glaxosmithkline, LLC for the acquisition of Influenza A/Astrakhan/3212/2020 (H5N8)-like master and working seed lots. The purpose of this task order is for Glaxosmithkline to provide influenza virus seeds to support pandemic preparedness efforts. Performance will take place in Research Triangle Park, North Carolina over an...
This is a delivery order issued under the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) Pandemic Influenza Preparedness and Response 2016-2021 contract vehicle. The $2,064,652.60 firm fixed price contract was awarded to Glaxosmithkline, LLC to provide a range of pharmaceutical goods and services, including influenza vaccines, antiviral medications, vaccine adjuvants, and COVID-19 treatments. Glaxosmithkline, a foreign-owned...
  • 75A50122D00002
    Indefinite Delivery Contract
  • 75A50122D00002-75A50124F61016
    Delivery Order

This is a firm fixed price delivery order awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency, to Glaxosmithkline, LLC to provide the acquisition of egg-based influenza master and working seed lots derived from a specific candidate vaccine virus, as well as fill-finish of any existing egg-based influenza vaccines. The order has a ceiling value of $1,650,050.61 and a completion date of February 21, 2026. No set-aside designation was used. Glaxosmithkline is the prime contractor and has previously held federal contracts and grants for a range of pharmaceutical products, including vaccines, treatments, and antivirals, with major customers across multiple civilian and defense agencies.

Generated 3/30/25, 12:46 AM